ResearcherActive in the last 2 years

Mithat Atak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-5168-3595; OpenAlex author ID A5048836331. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting NRF2/HO-1 and TNF-α Pathways. Last author DOI 10.2174/0118715206370057250421061226 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hatice Gül Dursun · 1 shared paper, 2025 · strength 0.28
- Paper Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting N… DOI 10.2174/0118715206370057250421061226 ↗
Sümeyra Çetinkaya · 1 shared paper, 2025 · strength 0.28
- Paper Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting N… DOI 10.2174/0118715206370057250421061226 ↗
İlknur Çınar Ayan · 1 shared paper, 2025 · strength 0.28
- Paper Enhanced Apoptosis in Pancreatic Cancer Cells through Thymoquinone-rich Nigella sativa L. Methanol Extract: Targeting N… DOI 10.2174/0118715206370057250421061226 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.